Psoriatic-Arthritis
Taltz® Approved for the Treatment of Psoriasis
Taltz® Approved for the Treatment of Psoriasis
Managing Inflammatory Arthritis From Checkpoint Inhibitors
Cancer patients treated with checkpoint inhibitors need to bring symptoms of joint pain to their doctors attention.
IL-23 inhibitor Tremfya effective for treatment of psoriatic arthritis
IL-23 inhibitor Tremfya effective for treatment of psoriatic arthritis
Solutions to Problem Itching
Itching can be relieved by the easily available Z and Z OTC medication combination.
Individuals With Psoriasis Have Increased Cancer Risk
Research suggests that individuals with psoriasis are at increased cancer risk and this may be associated with treatment
theRAConnection Survey Results Suggest Patients Don’t Discuss Treat to Target
theRAConnection Survey Results Suggest Majority of Patients Don’t Discuss Treat to Target Goals With Their Physician
A Third of Individuals with Psoriatic Arthritis Have Used Alternative Treatments
What natural or alternatives treatments have others used that have helped?
Chair Selection During the Covid-19 Pandemic
More and more of us are spending increasing hours in front of computers...
Exercise With Inflammatory Arthritis and Chronic Inflammatory Conditions
A leading doctor outlines the role of exercise in managing AS, RA, PsA, SLE and other inflammatory conditions.
Pregnancy - Psoriasis and Psoriatic Arthritis
Useful tips on successful pregnancy by individuals with psoriatic disease
Traveling with Inflammatory Arthritis
Traveling with RA, PsA and other inflammatory conditions can be stressful - make sure you are prepared.
Manage Your Inflammation By Improving Your Mind Body Health
Stress may play a role in inflammation that causes pain - learn about Tai Chi, Relaxation, and other coping techniques.
COVID-19 and Corticosteroids:
The adrenal gland, situated just above the kidneys, produces a number of hormones that are essential for normal body...
Biologics Offer Relief for People with Psoriasis
Newer biologic medications are giving patients more effective methods of reducing symptoms of psoriasis.
Drug Payment Assistance Programs for Rheumatoid & Psoriatic Arthritis
Drug Payment Assistance Programs for Rheumatoid & Psoriatic Arthritis
Management & Treatment of Psoriatic Arthritis
An overview of the types of medications used to treat Psoriatic Arthritis: DMARDS to NSAIDS
National Psoriasis Foundation Dietary Recommendations for Psoriatic Disease
National Psoriasis Foundation has released dietary recommendations for psoriasis and psoriatic arthritis.
Overview of Psoriatic Arthritis
Understand the symptoms and signs of psoriatic arthritis and how the condition is diagnosed
Psoriasis and Psoriatic Arthritis: What You See and What You Don’t
Discussion of how psoriatic disease affects women physically and emotionally in all aspects of work and life.
Rinvoq (upadacitinib) Effective in Phase 3 Psoriatic Arthritis Study
The JAK inhibitor Rinvoq represents a new treatment option for Psoriatic Arthritis
Is Methotrexate Alone the Best Initial Therapy for Psoriatic Arthritis?
New study suggests Enbrel alone more effective than MTX or combination.
Skyrizi Appears Superior to Humira for Treating Plaque Psoriasis
FDA approves third IL-23 inhibitor for treatment of plaque psoriasis.
Simponi Effective Initial Therapy for Psoriatic Arthritis
Simponi®(golimumab)is one of five marketed TNF inhibitors(TNFi) that is FDA approved for use in psoriatic arthritis(PsA)
Cosentyx Improves Mobility and Quality of Life for Individuals with Psoriasis
Doctors evaluated mobility, self-care, and activities of daily living in Cosentyx treated patients.
Is Bimekizumab the Next Advance in the Treatment of Psoriatic Arthritis?
Dual Inhibition of IL-17 appears promising for treatment of PsA according to University of Rochester led clinical trial
Updated Guidelines for Treating Psoriatic Arthritis Released
ACR recommends TNF biologic and "treat to target" approach for all individuals with Psoriatic Arthritis.
Filgotinib Selective JAK 1 Inhibitor Effective For Psoriatic Arthritis
Research suggests filgotinib can benefit psoriatic arthritis patients with difficult to control disease.
Psoriatic Arthritis Update From 2018 American College of Rheumatology Meeting
Researchers provide updates on Cosentyx, Tremfya, Otezla, Filgotinib, and Taltz treatment for Psoriatic Arthritis
Psoriasis Patients Taking Remicade Appear to be at Greater Risk of Infection
Doctors from the UK report on the increased risk of infection with Remicade in the British Journal of Dermatology
FDA Expands Cimzia Label for Use During Pregnancy
Cimzia provides women with autoimmune inflammatory disease the option to control disease during pregnancy
Frequently Asked Questions About Taltz® (Ixekizumab)
Understand the administration, side effects and answers to frequently asked questions about Taltz® (Ixekizumab).
Orencia Approved for Use in Psoriatic Arthritis
The U.S. Food and Drug Administration (FDA) has approved ORENCIA (abatacept) for the treatment of adults with active PsA
Individuals with psoriasis more likely to develop bone fractures
New research shows psoriasis increases risk of bone fractures.
Better Outcomes with Intensive Treatment in Psoriatic Arthritis
Better Outcomes with Intensive Treatment in Psoriatic Arthritis
Cosentyx Highly Effective for Treatment of Scalp Psoriasis
Cosentyx Highly Effective for Treatment of Scalp Psoriasis
Oral Methotrexate Effective for Juvenile Arthritis
Oral Methotrexate Effective for Juvenile Arthritis
FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis
FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis